Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CNO
CNO logo

CNO Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy CNO Financial Group Inc (CNO) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
43.610
1 Day change
-0.75%
52 Week Range
44.850
Analysis Updated At
2026/04/17
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

CNO Financial Group Inc is not a strong buy at the moment for a beginner investor with a long-term focus. While the technical indicators show some bullish momentum, the lack of significant positive catalysts, weak financial performance in the latest quarter, and mixed analyst sentiment suggest that it is better to hold off on investing in this stock for now.

Technical Analysis

The stock shows bullish momentum with SMA_5 > SMA_20 > SMA_200 and a positive MACD histogram (0.267). RSI is neutral at 69.671, and the stock is trading near its pivot level of 42.085. However, the regular market change is -0.44%, indicating slight downward pressure.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
3
Buy
10

Positive Catalysts

  • The stock has a 60% chance of increasing by 7.33% in the next week and 12.25% in the next month based on historical candlestick patterns. Additionally, bullish moving averages indicate some upward momentum.

Neutral/Negative Catalysts

  • The company's Q4 2025 financial performance showed a significant drop in net income (-49.21% YoY) and EPS (-45.40% YoY), which could weigh on investor sentiment. Analysts have mixed views, with one maintaining an Underperform rating. No recent insider or hedge fund activity suggests a lack of strong conviction in the stock.

Financial Performance

In Q4 2025, revenue increased by 3.68% YoY to $1.16 billion, but net income dropped significantly by 49.21% YoY to $92.9 million. EPS also fell by 45.40% YoY to 0.95, indicating weaker profitability.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts have mixed ratings. Keefe Bruyette re-initiated coverage with a Market Perform rating and a $46 price target, citing mixed fundamentals in the life insurance sector. Evercore ISI raised the price target to $43 but maintained an Underperform rating.

Wall Street analysts forecast CNO stock price to rise
3 Analyst Rating
Wall Street analysts forecast CNO stock price to rise
3 Buy
0 Hold
0 Sell
Strong Buy
Current: 43.940
sliders
Low
47
Averages
48
High
50
Current: 43.940
sliders
Low
47
Averages
48
High
50
Keefe Bruyette
Ryan Krueger
Market Perform
initiated
$46
AI Analysis
2026-03-26
Reason
Keefe Bruyette
Ryan Krueger
Price Target
$46
AI Analysis
2026-03-26
initiated
Market Perform
Reason
Keefe Bruyette analyst Ryan Krueger re-initiated coverage of CNO Financial with a Market Perform rating and $46 price target. The life insurance sector presents a mixed fundamental picture, and while companies have reduced liability tail risk, improved free cash flow conversion, and benefited from stronger growth, they face intensifying competition, rising investment leverage, greater balance sheet complexity, and eventual fading macro tailwinds, the analyst tells investors in a research note.
Evercore ISI
Underperform
maintain
$42 -> $43
2026-02-18
Reason
Evercore ISI
Price Target
$42 -> $43
2026-02-18
maintain
Underperform
Reason
Evercore ISI raised the firm's price target on CNO Financial to $43 from $42 and keeps an Underperform rating on the shares.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CNO
Unlock Now

People Also Watch